<DOC>
	<DOCNO>NCT02522832</DOCNO>
	<brief_summary>A GMP rhinovirus manufacture accord GMP characterise human volunteer human viral challenge model .</brief_summary>
	<brief_title>Discovering New Treatments Asthma COPD . A New Human Rhinvovirus Human Challenge</brief_title>
	<detailed_description>Human Rhinovirus infection important precursor asthma chronic obstructive pulmonary disease exacerbation Human Viral Challenge model may provide powerful tool study chronic respiratory disease . In study report production human characterisation new HRV-16 challenge virus produce specifically purpose . An HRV-16 isolate 18 year old experimentally infect healthy female volunteer ( University Virginia Children 's Hospital , USA ) obtain appropriate medical history consent . We manufacture new HRV-16 stock minimal passage WI-38 cell line Good Manufacturing Practice condition . Having first subject stock rigorous adventitious agent test determine virus suitability human use , conduct initial safety pathogenicity clinical study adult volunteer dedicate clinical quarantine facility London .</detailed_description>
	<criteria>Young healthy adult determine medical history , physical examination , serology ( HIV Hepatitis B C ) clinical laboratory test . Female subject require provide history reliable contraceptive practice . include ; asthma , hypersensitivity mercurials chicken egg , anatomic neurologic abnormality impair gag reflex contribute aspiration , chronic nasopharyngeal complaint , abnormal electrocardiogram ( ECG ) , febrile illness significant symptom upper respiratory infection day Subjects use medication product rhinitis nasal congestion , Subject receive systemic glucocorticoid within 1 month , cytotoxic immunosuppressive drug within 6 month study start . Subjects agree smoke quarantine phase .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>August 2015</verification_date>
</DOC>